Veltkamp R, Domoki F, Bari F, Louis T M, Busija D W
Stroke Research Center and Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston Salem, NC 27157- 1083, USA.
Stroke. 1999 Jan;30(1):148-52. doi: 10.1161/01.str.30.1.148.
BACKGROUND AND PURPOSE--Cerebral arteriolar dilation to N-methyl-D-aspartate (NMDA) is a neuronally mediated process that is sensitive to cerebral ischemia. We tested the hypothesis that pretreatment with transcription or translation inhibitors preserves the vascular response to NMDA after global cerebral ischemia. METHODS--Pial arteriolar diameters were measured in anesthetized piglets by use of a closed cranial window and intravital microscopy. Arteriolar responses to NMDA (10(-5) and 10(-4) mol/L) were measured before and 1, 2, and 4 hours after 10 minutes of ischemia. Ischemia was induced by increasing intracranial pressure. Subgroups were pretreated with vehicle, topical actinomycin D (Act-D) 10(-5) or 10(-6) mol/L, or intravenous cycloheximide (CHX) 1.0 or 0.3 mg/kg 15 minutes before ischemia. The effects of Act-D and CHX on vascular responses to NMDA without preceding ischemia were also examined. RESULTS--In the vehicle group, arteriolar responses to NMDA were clearly attenuated 1 hour after ischemia but returned to baseline at 2 to 4 hours. Preischemic compared with 1 hour postischemic arteriolar dilation to NMDA was 10+/-2% versus 1+/-0% at 10(-5) mol/L and 40+/-4% versus 20+/-4% at 10(-4) mol/L NMDA (mean+/-SEM; both P<0.05, n=7). In contrast, pretreatment with Act-D resulted in preservation of the arteriolar responses to NMDA 1 hour after ischemia. For 10(-6) mol/L (n=5) of Act-D, dilations were 6+/-2% versus 6+/-2% at 10(-5) mol/L and 51+/-9% versus 39+/-10% at 10(-4) mol/L of NMDA. For 10(-5) mol/L (n=5) of Act-D, arterioles dilated by 7+/-2% versus 7+/-2% at 10(-5) mol/L and 38+/-4% versus 35+/-4% at 10(-4) mol/L NMDA. Similarly, CHX preserved NMDA-induced vasodilation. For 0.3 mg/kg of CHX (n=5), dilations were 8+/-2% versus 8+/-1% at 10(-5) mol/L and 39+/-4% versus 28+/-6% at 10(-4) mol/L NMDA. For 1.0 mg/kg of CHX (n=5), arterioles dilated by 10+/-2% versus 6+/-2% at 10(-5) mol/L and 37+/-7% versus 35+/-6% at 10(-4) mol/L NMDA. In experiments without ischemia, NMDA-induced vasodilation before and 85 minutes after administration of Act-D or CHX was not significantly different. CONCLUSIONS--Vascular responses of cerebral arterioles to NMDA after ischemia are preserved by pretreatment with either Act-D or CHX. Without preceding ischemia, Act-D and CHX do not potentiate neuronal-vascular responses to NMDA. Our results suggest that continued or augmented protein synthesis is involved in the transient attenuation of NMDA-induced dilation during the early reperfusion phase and that inhibitors of protein synthesis may protect neurons against ischemic stress.
背景与目的——脑小动脉对N-甲基-D-天冬氨酸(NMDA)的扩张是一个由神经元介导的过程,对脑缺血敏感。我们检验了这样一个假设,即转录或翻译抑制剂预处理可在全脑缺血后保留血管对NMDA的反应。方法——通过使用封闭的颅骨窗口和活体显微镜,在麻醉的仔猪中测量软脑膜小动脉直径。在缺血10分钟之前以及之后1、2和4小时测量小动脉对NMDA(10⁻⁵和10⁻⁴mol/L)的反应。通过升高颅内压诱导缺血。在缺血前15分钟,将亚组用赋形剂、局部应用10⁻⁵或10⁻⁶mol/L放线菌素D(Act-D)或静脉注射1.0或0.3mg/kg环己酰亚胺(CHX)进行预处理。还研究了Act-D和CHX对无先前缺血情况下血管对NMDA反应的影响。结果——在赋形剂组中,缺血后1小时小动脉对NMDA的反应明显减弱,但在2至4小时恢复到基线水平。与缺血后1小时相比,缺血前小动脉对10⁻⁵mol/L NMDA的扩张为10±2%对1±0%,对10⁻⁴mol/L NMDA为40±4%对20±4%(平均值±标准误;P均<0.05,n = 7)。相比之下,Act-D预处理导致缺血后1小时小动脉对NMDA的反应得以保留。对于10⁻⁶mol/L(n = 5)的Act-D,对10⁻⁵mol/L NMDA的扩张为6±2%对6±2%,对10⁻⁴mol/L NMDA为51±9%对39±10%。对于10⁻⁵mol/L(n = 5)的Act-D,小动脉对10⁻⁵mol/L NMDA的扩张为7±2%对7±2%,对10⁻⁴mol/L NMDA为38±4%对35±4%。同样,CHX保留了NMDA诱导的血管舒张。对于0.3mg/kg的CHX(n = 5),对10⁻⁵mol/L NMDA的扩张为8±2%对8±1%,对10⁻⁴mol/L NMDA为39±4%对28±6%。对于1.0mg/kg的CHX(n = 5),小动脉对10⁻⁵mol/L NMDA的扩张为10±2%对6±2%,对10⁻⁴mol/L NMDA为37±7%对35±6%。在无缺血的实验中,给予Act-D或CHX之前以及之后85分钟,NMDA诱导的血管舒张无显著差异。结论——Act-D或CHX预处理可保留缺血后脑小动脉对NMDA的血管反应。在无先前缺血的情况下,Act-D和CHX不会增强神经元-血管对NMDA的反应。我们的结果表明,持续或增加的蛋白质合成参与了再灌注早期NMDA诱导的扩张的短暂减弱,并且蛋白质合成抑制剂可能保护神经元免受缺血应激。